Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Bayside Health.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Bayside Health
Information provided by:
Bayside Health
ClinicalTrials.gov Identifier:
NCT00164060
First received: September 13, 2005
Last updated: June 6, 2007
Last verified: September 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Show Detailed Description
The purpose of this study is to examine the effect of GB virus C (GBV-C) on the natural history of chronic hepatitis C virus (HCV) infection in subjects co-infected with HIV and HCV. The other aspect of the study is to assess the effect of GBV-C on the severity of liver disease due to chronic hepatitis C in subjects co-infected with HIV and HCV. This will be done by determining the point prevalence of co-infection retrospectively then following that cohort prospectively. In addition, further individuals will be recruited in a prospective manner.
Condition |
---|
Hepatitis C HIV Infections |
Study Type: | Observational |
Study Design: | Observational Model: Defined Population Observational Model: Natural History Time Perspective: Longitudinal Time Perspective: Retrospective |
Official Title: | Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection |
Resource links provided by NLM:
Further study details as provided by Bayside Health:
Estimated Enrollment: | 200 |
Study Start Date: | February 2004 |
Estimated Study Completion Date: | May 2007 |
Eligibility
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Sera available and appropriate for testing, including serial sera over a period of time (retrospective analysis)
- HIV serology positive.
- Unequivocal HCV antibody positive or HCV RNA positive.
Exclusion Criteria:
- Those without sera available.
- Those unwilling to give informed consent.
- Persons with hepatitis B virus infection, as defined by the presence of hepatitis B surface antigen and/or hepatitis B virus DNA positive.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00164060
Contacts
Contact: Mark D Berzsenyi, MBBS | 0417 574 015 | m.berzsenyi@alfred.org.au |
Locations
Australia, Victoria | |
Alfred Hospital | Recruiting |
Melbourne, Victoria, Australia, 3181 | |
Contact: Mark D Berzsenyi, MBBS 0417 574 015 m.berzsenyi@alfred.org.au |
Sponsors and Collaborators
Bayside Health
Investigators
Principal Investigator: | Mark D Berzsenyi, MBBS | Alfred Hospital/Bayside Health |
Study Director: | Stuart R Roberts, MBBS | Alfred Hospital/Bayside Health |
More Information
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Keywords provided by Bayside Health:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on March 03, 2013
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: | NCT00164060 History of Changes |
Other Study ID Numbers: | 35/04 |
Study First Received: | September 13, 2005 |
Last Updated: | June 6, 2007 |
Health Authority: | Australia: Human Research Ethics Committee |
Keywords provided by Bayside Health:
HCV HIV co-infection |
Additional relevant MeSH terms:
Acquired Immunodeficiency Syndrome HIV Infections Hepatitis Hepatitis A Hepatitis C Immunologic Deficiency Syndromes Virus Diseases Lentivirus Infections Retroviridae Infections RNA Virus Infections |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Slow Virus Diseases Immune System Diseases Liver Diseases Digestive System Diseases Hepatitis, Viral, Human Enterovirus Infections Picornaviridae Infections Flaviviridae Infections |
ClinicalTrials.gov processed this record on March 03, 2013